US loss of exclusivity · Neuroscience

Ocrevus

Roche

2029US biosimilars from
2025Today: 20262037
2025 worldwide sales
≈$8.4B
Date basis
Patent-expiry estimate
US biosimilars
In clinical trials
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Ocrevus timeline →